NBIX
Neurocrine Biosciences Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Neurocrine Biosciences Inc
145.87
−0.23 · −0.16%
post 154.00 +5.58%
No thesis.
Fund move
Fund move
News
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $2.3B | 13.46% | +2.44% | |
| 2 | JPMorgan ChaseJPMorgan Chase | $1.1B | 6.34% | +17.58% | |
| 3 | Dodge & COXDodge & COX | $941.2M | 5.48% | +2.26% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $838.3M | 4.88% | +5.24% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $766.0M | 4.46% | +0.74% | |
| 6 | State StreetState Streetindex-like | $739.1M | 4.30% | +0.71% | |
| 7 | AQR Capital ManagementAQR | $643.5M | 3.75% | −22.70% | |
| 8 | Renaissance TechnologiesRenaissance Technologies | $393.7M | 2.29% | −3.43% | |
| 9 | Geode Capital ManagementGeodeindex-like | $359.6M | 2.09% | +0.10% | |
| 10 | Two Sigma InvestmentsTwo Sigma | $349.9M | 2.04% | −32.16% | |
| 11 | Vestal Point CapitalVestal Point Capital | $316.8M | 1.85% | +50.40% | |
| 12 | BNP Paribas Investment PartnersBNP Paribas Investment Partners | $251.9M | 1.47% | +0.03% | |
| 13 | Morgan StanleyMorgan Stanley | $222.2M | 1.29% | +8.15% | |
| 14 | RTW InvestmentsRTW | $213.7M | 1.24% | +19.38% | |
| 15 | Northern TrustNorthern Trustindex-like | $212.3M | 1.24% | +1.36% | |
| 16 | InvescoInvesco | $181.6M | 1.06% | +202.61% | |
| 17 | Charles Schwab Investment ManagementCharles Schwabindex-like | $164.2M | 0.96% | +7.92% | |
| 18 | Norges BankNorges Bankindex-like | $164.1M | 0.96% | — | |
| 19 | First Trust AdvisorsFirst Trust | $155.6M | 0.91% | −3.76% | |
| 20 | Dimensional Fund AdvisorsDimensional | $123.5M | 0.72% | +2.97% | |
| 21 | Jacobs Levy Equity ManagementJacobs Levy Equity | $122.4M | 0.71% | +39.56% | |
| 22 | Bank of New York MellonBank of New York Mellonindex-like | $117.8M | 0.69% | −0.48% | |
| 23 | SwedbankSwedbank | $109.7M | 0.64% | +12.37% | |
| 24 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $109.2M | 0.64% | +2.12% | |
| 25 | Goldman Sachs GroupGoldman Sachs | $108.8M | 0.63% | +77.91% |
781 managers report $17.2B of Neurocrine Biosciences on form 13F for the quarter ended Jun 30 '26. 62 of them hold 80% of it; BlackRock is largest at 13.46%.
Expected move
Inputsspot 145.35exp Feb 19ATM strike 145ATM straddle 25.20IV 39%